Back to Newsroom
Back to Newsroom

Cannabis Kinetics Corp.'s Volume Soars on News of Acquisition

Thursday, 23 October 2014 07:30 AM

Topic:

Cannabis Kinetics Corp. (OTCQB: CANK) experienced robust stock volume Oct. 22, with 156,680 shares changing hands, more than 3 times higher than its 30-day average volume of 43,629 shares.

The surge in volume come of the heels of an announcement from Westminster, Colo.-based mineral company that it has signed an agreement for the purchase of the operating assets of The Big Tomato, an established Denver area store, warehouse distribution facility, and online hydroponics and indoor garden supplier.

As per terms of the binding Merger Agreement, Cannabis Kinetics will acquire all the operating assets of The Big Tomato for a total purchase price of $2,400,000 in cash ($400,000 payable at closing and the balance payable over two years in eight (8) equal installments of $250,000 commencing six months from the closing), and 3,000,000 restricted common shares of Company stock.

CANK's share price closed at $1.45, up 4 cents, or 2.84%, from its share price of $1.41 the previous day.

Find out what could be the best investor's move when it comes to CANK by getting the complete report here or by cutting and pasting the following link in your Web browser:

www.sixfigurestockpicks.com

NanoTech Entertainment Adds 50 Super-Star Concerts to Its Steaming Content

NanoTech Entertainment Inc.'s (OTCPink: NTEK) stock volume surged Oct. 22, with 6.4 million shares changing hands, substantially higher than its 30-day average stock volume of 4 million shares.

The uptick in the San Jose Calif.-based entertainment technology company comes on the heels of its recent announcement that it has entered into a distribution agreement with Eagle Rock Entertainment to add more than 50 legendary concerts and music industry documentaries to NanoTech's UltraFlix(TM) all 4K Ultra HD network.

According to NanoTech, Eagle Rock Entertainment, a subsidiary of Universal Music Group, and the world's largest producer and distributor of music programming, will provide NanoTech with over 50 titles. NanoTech's 4K Studios is processing the films using its proprietary technology to provide subscribers with an enhanced viewing experience for these films.

Some of the additions to the UltraFlix network's growing library of 4K content include concerts and documentaries featuring renowned musicians and bands including: Elton John, Aerosmith, Pink Floyd, Santana, The Doors, Usher, Johnny Cash, Paul McCartney, Alice Cooper, The Who, Queen, The Rolling Stones, Bruce Springsteen, Peter Frampton and Duran Duran.

By adding more than 50 new offerings, UltraFlix will enable subscribers to choose from nearly 500 hours of pristine 4K Ultra HD content in a broad range of venues plus 100 hours of free content-all while expanding its lead in the 4K Ultra HD content race. As the world's largest source for 4K content, UltraFlix has become the preferred 4K Smart TV App for leading 4K TV manufacturers including Sony, Vizio and others that are in the process of completing their testing and integration of the only dedicated 4K streaming app. Recently, UltraFlix provided the content for demonstrations featuring 4K Ultra HD televisions from Samsung, Sony and LG at Best Buy's Ultra HD viewing events.

Reports Net Profit

In addition to this, NanoTech has had some very solid financials lately, especially for a penny stock.

Here's a summary of NTEK's latest 10-Q for its third quarter that ended Mar. 2014:

-$376,000 Q3 net profit

-$34, 000 in cash

-$5.1 million in Q3 sales

-$582, 000 in total liabilities

On Oct. 22, NTEK's share value closed at 6 cents, unchanged from its close of the previous day.

Find out what could be the best investor's move when it comes to NTEK by getting the complete report here or by cutting and pasting the following link in your Web browser:

www.sixfigurestockpicks.com

Terra Tech Corp.'s Stock Volume Soars

Terra Tech Corp.'s (OTCQB: TRTC) shock volume soared Oct. 22, with 2.9 million shares changing hands, nearly double its 30-day average volume of $15 million shares.

The low volume comes on the heels of the California-based maker of marijuana cultivating equipment recent announcement that its long-awaited testing of cannabinoid extraction has begun at its facility in Northern California.

The facility was built in response to what Terra Tech views as an increase in demand for high grade CBD as well as other cannabis extracts.

Terra Tech has also been focusing on its Nevada operation.

Formation of MediPharm LLC

On Apr. 2, Terra Tech formed MediPharm LLC. a wholly owned Nevada LLC that has been created to compete for medical cannabis permits in Nevada.

This was just one of the moves made by the company to firmly establish itself in the medical marijuana market.

Latest Quarterly Financials 

Here's a summary of TRTC's latest 10-Q covering the quarter ending Jun. 30:

- $4.5 million net loss

- $2.6 million cash on hand

- $7.1 million current liabilities

- $3.7 million revenue

On Oct. 22, TRTC's share price closed at 36 cents, up 3 cents, or 8.25% from the previous day’s close of 33 cents.

Find out what could be the best investor's move when it comes to TRTC by getting the complete report here or by cutting and pasting the following link in your Web browser:

www.sixfigurestockpicks.com

Titan Medical Inc. Stock Volume Soars

Titan Medical Inc.'s (OTCQX: TITXF) stock volume was soared Oct. 22, with 286,496 shares changing hands, substantially higher than its 30-day average volume of 184,142 shares.

Developing 2 Robotic Products

There is not much information about the Toronto-based surgical robotic device maker, because it is basically in its developmental stage.

However, it is working on its Single Port Orifice Robotic Technology, SPORT(TM) Surgical System, that it says is comprised of a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures.

This includes a workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures.

The SPORT(TM) Surgical System is being designed to expand robotic surgery into both simple and complex areas of surgical specialties and procedures that are currently under-serviced. It is also being designed to allow surgeons to perform procedures within small- to medium-size surgical spaces, such as general surgery and cholecystectomy.

How long and at what cost it will take to fully develop this product and bring it to market remains to be seen.

On Oct. 13, TITXF's share value closed at $2.01, down 2 cents from its closing price of $1.99 the previous day.

Find out what could be the best investor's move when it comes to TITXF by getting the complete report here or by cutting and pasting the following link in your Web browser:

www.sixfigurestockpicks.com

 

ABOUT US:

www.sixfigurestockpicks.com issues momentum alerts on stocks that can provide gains to day traders.

www.sixfigurestockpicks.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.

www.sixfigurestockpicks.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the www.sixfigurestockpicks.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: www.sixfigurestockpicks.com

Disclosure

www.sixfigurestockpicks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.

 

Topic:
Back to newsroom
Back to Newsroom
Share by: